SGD Pharma's acquisition of Alphial S.r.l. marks a strategic milestone in the Group's expansion into pharmaceutical tubular glass packaging.
On August 28, 2025, SGD Pharma announced an agreement with Italian private equity firm Entangled Capital to acquire Alphial S.r.l., an Italian manufacturer of pharmaceutical glass ampoules, vials and Ready-to-Use (RTU) packaging.
The acquisition strengthened SGD Pharma's industrial presence in Europe and expanded its capabilities in tubular glass manufacturing.
Following the completion of the acquisition, Alphial officially joined SGD Pharma in November 2025.
Strengthening SGD Pharma's European Manufacturing Network
Based in Italy, Alphial specializes in tubular glass packaging for pharmaceutical applications.
At the time of the acquisition announcement, the company employed more than 220 people across four manufacturing sites in Italy.
Its product portfolio included:
- Pharmaceutical glass ampoules.
- Tubular glass vials.
- Ready-to-Use (RTU) packaging solutions.
By integrating Alphial's expertise, SGD Pharma expanded its European manufacturing network and complemented its established molded glass capabilities.
The acquisition also strengthened the Group's ability to offer pharmaceutical customers a broader range of primary glass packaging solutions.
Expanding Tubular Glass and RTU Capabilities
The SGD Pharma Alphial acquisition forms part of a broader strategy to develop tubular glass manufacturing capabilities worldwide.
In the years leading up to the acquisition, SGD Pharma had already invested in tubular glass and Ready-to-Use solutions.
One important initiative was its joint venture with Corning to establish a glass tubing facility near SGD Pharma's Vemula plant in India.
The project was designed to strengthen supply chain security, improve quality control and reduce environmental impact.
Alphial's manufacturing expertise complemented these investments.
Together, these developments reinforced SGD Pharma's position in pharmaceutical glass packaging across different manufacturing technologies and geographical markets.
A Shared Vision for Growth and Innovation
The acquisition brought together complementary industrial capabilities and a shared ambition for long-term growth.
At the time of the announcement, Olivier Rousseau, CEO of SGD Pharma, welcomed the agreement as an important milestone in the Group's development.
He emphasized the opportunity to better serve pharmaceutical customers through an expanded portfolio of products and services.
Fabio Invernizzi, General Manager of SGD Pharma's West Business Unit, also highlighted the investments already made in tubular glass and RTU packaging.
He expressed his enthusiasm for working with Alphial's teams to advance the Group's industrial strategy.
For Valerio Marchi, CEO of Alphial S.r.l. at the time of the announcement, joining SGD Pharma represented an opportunity to support Alphial's growth while improving its product offering and industrial performance.
These perspectives reflected a common objective: combining expertise to strengthen competitiveness and create long-term value.
From Acquisition to Integration
The agreement announced in August 2025 was initially subject to Italian foreign direct investment clearance.
Following completion of the acquisition, Alphial officially became part of SGD Pharma in November 2025.
The Group welcomed Alphial employees through dedicated events across its Italian manufacturing sites.
This milestone marked the beginning of closer collaboration between the teams and created opportunities to share technical expertise, manufacturing experience and best practices.
Beyond expanding industrial capabilities, the integration brought together people and skills across the Group.
Supporting Pharmaceutical Customers Worldwide
The acquisition of Alphial represents an important step in SGD Pharma's long-term growth strategy.
By combining molded and tubular glass manufacturing expertise, the Group strengthened its ability to address different pharmaceutical packaging requirements.
The expanded portfolio also supports customers looking for glass ampoules, vials and Ready-to-Use packaging solutions.
Discover SGD Pharma's pharmaceutical glass packaging portfolio and explore how our experts can support your specific requirements.